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ABSTRACT
A new coronavirus disease called COVID-19 was declared by World Health 
Organization (WHO). The COVID-19 may complicated into many other 
conditions, including neurologic. One among this neurologic complication 
is stroke. This paper aimed to report a case of ischemic stroke in COVID-19 
positive patient in Yogyakarta, Indonesia. A male patient, 42 years old, came 
to emergency department with weakness in his right arm for two days as his 
main complain. He also had face drop on the right side, cough, and shortness 
of breath. He had a history of hyperthyroid and type II diabetes mellitus. The 
brain CT Scan showed a lacunar infarct in the left lentiform nucleus. Patient had 
nasopharynx and oropharynx swab to be checked for the presence of COVID-19 
and the result was positive.The pathophysiology of stroke in COVID-19 include 
the hyperactivation of inflammatory factors that causes a fatal inflammatory 
storm. It also cause a damage of coagulation system which causing the D-dimer 
and platelet abnormalities, hypercoagulability from critical illness and 
cardioembolism from virus-related cardiac injury. Moreover, COVID-19 may 
cause a direct role in viral infection in central nervous system. In conclusion, 
ischemic stroke can be present along with COVID-19.
ABSTRACT
Penyakit akibat infeksi corona virus baru yang disebut COVID-19 telah 
diumumkan oleh Badan Kesehatan Dunia (World Health Organization / WHO). 
COVID-19 kemungkinan dapat menyebabkan berbagai komplikasi termasuk 
gangguan neurologi. Salah satu komplikasi neurologi ini adalah stroke. Paper 
melaporkan sebuah kasus stroke iskemik pada pasien COVID-19 positif di 
Yogyakarta, Indonesia. Seorang pasien pria berumur 42 tahun dibawa ke 
instalasi gawat darurat dengan keluhan utama kelemahan di lengan kanan 
sejak dua hari sebelumnya. Pasien menderita wajah perot pada sisi kanan, 
batuk, dan sesak nafas. Pasien juga punya riwayat hipertiroid dan diabetes 
mellitus tipe II. Hasil CT scan kepala menunjukkan infark lakuner pada inti 
lentiformis sinistra. Pasien diambil apusan orofaring dan nosafaring untuk 
memastikan menderita COVID-19 dan hasilnya positif. Patofisiologi stroke pada 
COVID-19 meliputi hiperaktivasi faktor inflamasi yang menyebabkan badai 
inflamasi fatal. Selain itu stroke iskemik pada pasien COVID-19 dapat terjadi 
akibat adanya abnormalitas D-dimer dan trombosit, hiperkoagulabilitas, 
serta terjadinya kardioemboli karena gangguan fungsi jantung. Diperkirakan 
COVID-19 juga dapat menyebabkan infeksi langsung pada sistem saraf pusat. 
Dapat disimpulkan, stroke iskemik dapat terjadi bersamaan dengan COVID-19.
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INTRODUCTION
A new coronavirus disease called 
COVID-19 caused by severe acute 
respiratory syndrome coronavirus 2 
(SARS-CoV-2) was declared by World 
Health Organization (WHO) on February 
11th, 2020.1 The WHO then announced 
that COVID-19 as a pandemic on March 
11th, 2020.2 The first case of confirmed 
COVID-19 in Indonesia was declared 
directly by President Joko Widodo on 
March 2nd2020.3 Till May 8th, 2020, the 
number of positive COVID-19 patients 
in Indonesia was 12.776 patients, 2381 
among them were recover and 930 
patients were pass away.4 This number 
is expected to keep increasing.
The COVID-19 may complicated 
into many other conditions, such as 
acute respiratory distress syndrome, 
cardiovascular complications, septic 
shock, and acute kidney injury.5 There are 
also several case reports on neurologic 
complication among COVID-19 patients.6-8 
One among the neurologic complication 
is stroke. However, the corelation 
between COVID-19 and stroke is not 
yet concluded. The pathophysiology of 
ischemic stroke and COVID-19 is also not 
yet fully understood. There is still very 
limited study discussing on neurologic 
complication and stroke in COVID-19 in 
Indonesia. This paper aimed to report 
a case of ischemic stroke in positive 
COVID-19 patient.
CASE REPORT
A male, 42 years old patient, came 
to emergency department of Panti Rapih 
Hospital, Yogyakarta with weakness 
in his right arm for 2 days as his main 
complain. He also had face drop on the 
right side, cough, and shortness of breath. 
His sputum has a cloudy appearance. 
About a week before this symptoms, 
he was travelling to South Sulawesi to 
attend an event. Other symptoms such 
as fever, sore throat, runny nose, skin 
rash, and diarrhea were denied. His 
weight decreased for the last 3-6 months, 
from 65 kg to 49 kg. He had a history 
of hyperthyroid and type II diabetes 
mellitus. The patient and his family did 
not remember when the disease was 
first diagnosed. These diseases were not 
controlled routinely.
Vital signs at the admission i.e.: 
blood pressure (BP) was 122/85 mmHg, 
heart rate (HR) was 125 times per minute 
(tpm), respiratory rate (RR) was 26 tpm, 
and temperature (T) was 36.5ºC. Patient’s 
random blood glucose was 215 mg/dL. 
The physical examination revealed that 
the patient had paresis in right facial 
nerve. The muscle strength was 2 out of 5 
on right arm while the others are normal. 
The breathing sound was normal.
The hematology test at the admission 
compared to sixth and seventh day of 
observation showed in TABLE 1. The 
results of liver function test and kidney 
function test showed in TABLE 2. The 
natrium level was 132 mmol/L and 
kalium level was 4.7 mmol/L. Patient had 
a non reactive result for HbsAg and anti 
Human Immunodeficiency Virus (HIV). 
The free T4 was increase (25.8 pmol/L) 
and TSHs was normal (1.095 uIU/mL).
The patient underwent inpatient 
care at isolation ward. Patient had 
nasopharynx and oropharynx swab on 
March 29th and 30th, 2020. Corona virus is 
transmitted through droplets and infects 
human after enter the respiratory tract. 
Nasopharynx and oropahrynx swab 
are the recommended way to detect 
the presence of corona virus in upper 
respiratory tract.14 The specimens were 
checked by Center for Environmental 
Health Engineering and Disease 
Control (Balai Besar Teknik Kesehatan 
Lingkungan dan Pengendalian Penyakit/ 
BBTKLPP), as a center laboratory for 
COVID-19 in Yogyakarta. The result for 
COVID-19 was positive. This patient had 
a critical NLR and increase significantly 
from the day of admission to the seventh 
day of treatment (9.59 to 18.45). His ALC 
was also decrease gradually from 1760 
at the day of admission to 690.9 at the 
seventh day of treatment (TABLE 1). 
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TABLE 1. The results of hematology test
Parameters
Admission
(first day)
Sixth 
day
Seventh 
day
Hemoglobin (g%) 14.0 12.1 11.3
WBC (x 10+3/µL) 20.0 10.6 14.1
RBC (x 10+3/µL) 5.05 4.27 4.12
Hematocrit (%) 40.6 32.9 32.1
Platelets (x 10+3/µL) 364 208 207
Eosinophil (%) 0.0 0.0 0.0
Basophil (%) 0.2 0.2 0.1
Neutrophil (%) 84.4 75.0 90.4
Lymphocyte (%) 8.8 8.5 4.9
Monocyte (%) 6.6 16.3 4.6
NLR 9.59 8.82 18.45
ALC 1760 901 690.9
MCV (fL) 80.4 77.0 77.9
MCH (pg) 27.7 28.3 27.4
MCHC (g/dL) 34.5 36.8 35.2
RDW-CV (%) 13.3 13.2 13.9
WBC: White blood cells, RBC: Red blood cells, NLR: 
Neutrophil-to-lymphocyte ratio, ALC: Absolute 
lymphocyte count, MCV: Mean corpuscular volume, 
MCH: Mean corpuscular hemoglobin, MCHC: Mean 
corpuscular hemoglobin concentration, RDW-CV: 
Red cell distribution width
He had a chest x-ray and brain CT 
scan. Radiologist conclude that his lung is 
normal with cardiomegaly (FIGURE 1). The 
brain CT Scan showed a lacunar infarct in 
the left lentiform nucleus (FIGURE 2).
FIGURE 1. Chest X-Ray at the admission
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FIGURE 2. Patient’s Brain CT Scan
The treatment for the patient during 
inpatient care were 4 L/min oxygenation 
with nasal cannula, levofloxacin 
intravenous (IV) 750 mg per 24 h, vitamin 
C IV 400 mg 1 times per day (s.i.d), 
lopinavir/ritonavir 2 tablets 2 times per 
day (b.i.d), chloroquine 500 mg b.i.d, and 
ambroxol 3 times per day (t.i.d), codeine 
10 mg t.i.d, thiamizole 10 mg s.i.d, and 
glicazide 80 mg s.i.d if his blood sugar > 
200 mg/dL.
TABLE 2. The results of liver and kidney fuction test
Parameters
Admission
(first day)
Seventh 
day
SGOT (U/L) 49.0 331.0
SGPT (U/L) 48.0 1268.0
Ureum (mg/dL) 58.0 246
Creatinine (mg/dL) 1.49 5.30
SGOT: Serum glutamic oxaloacetic transami-
nase, SGPT: Serum glutamic pyruvic transam-
inase
At the second day of treatment, 
there was a bilateral rhonchi sound. The 
muscle strength was 3 on superior limbs 
and 4 for inferior limbs. The National 
Institutes of Health Stroke Scale (NIHSS) 
on admission was 4. Patient had a low 
LDL cholesterol (21 mg/dL) and normal 
for other lipid profile (76 mg/dL total 
cholesterol, 52 mg/dL LDL cholesterol, 
and 99 mg/dL triglyceride). Patient 
had an urinalysis. The results were 
>1.030 for specific gravity, negative for 
nitrit, glucose, keton, urobilinogen, and 
bilirubin, +2 for blood, pH 5.5, +2 for 
protein, 25/µL for esterase leukocyte, 
75.6/µL RBC, 6.9/µL WBC, 6.2/µL epitel 
cells, 3.7/µL polygonal epitel, 2.1/
µL hyaline cylinder, 1.5/µL patology 
cylinder, 66.8/µL bacteries, 0.1/µL crystal, 
0.0/µL fungi and mucous, and 12.8 mS/
cm for conductivity. Patients advised to 
do a self-physiotheraphy for his limbs at 
the second day.
On the third day of treatment, 
patient had a hypoglycemia (nocturnal 
blood glucose 54 mg/dL). Therefore, he 
was given a 2 fL of D40%. The next day, 
patient felt nauseous, was unable to sleep 
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and had a hiccup which did not stop until 
the next morning. Therefore we treated 
the patient with 4 mg ondancetron IV, 0.5 
mg alprazolam tablet, 40 mg omeprazole 
IV and 25 mg clorpromazine tablet.
On the sixth day of treatment, 
patient’s condition was getting worse. 
He had a severe dyspnea. The vital signs 
i.e.: BP was 110/70 mmHg, RR was 30 
tpm, and SpO2 was 97%. Patient checked 
for CD4 and the result was normal (435 
cell/µL). An evaluation chest x-ray was 
performed. His lung showed a worse 
condition i.e. right bronchopneumonia 
with cardiomegaly. He got a nebulizer 
with a combination of ipratropium 
bromide/salbutamol and fluticasone 
propionate per 6 hours, furosemide 
20 mg IV, methylprednisolone 62,5 
mg IV, omeprazole 40 mg IV s.i.d, and 
hydroxychloroquin 200 mg t.i.d.
FIGURE 3. Chest X-Ray at the sixth day of treatment
On the seventh day, the patient was 
unresponsive. The consciousness was 
sopor, BP was 98/72 mmHg, HR was 76 
tpm, RR was 30 tpm, T was 36.2ºC, SaO2 
was 86%, and random blood glucose was 
118 mg/dL. The result of hematology, 
liver, and kidney function tests showed 
a worsen condition (TABLE 1 and 2). 
The blood gass analysis showed a sign 
of acidosis (FiO2 95%, pH 7.338, PCO2 
22.0 mmHg, PO2 66.1 mmHg, HCO3 12.0 
mmol/L, O2 saturation 92.2%, BE -11.8 
mEq/L, TCO2 12.7 mmol/L, O2-CT 11.2%, 
AADO2 568.6 mmHg, barometer pressure 
736.70 mmHg).  In a short period, he got 
cardiac and respiratory failure. The time 
of death was on the seventh day from 
admission at 07.10 am.
DISCUSSION
This is the first case report which 
discuss ischemic stroke in patient with 
COVID-19 positive in Indonesia. As 
mentioned  above, this  patient  has 
a history of type II diabetes mellitus. 
Diabetes mellitus has been known 
as one of a major risk factors for 
ischemic stroke by induce vascular 
endothelial dysfunction, increased 
early-age arterial stiffness, systemic 
inflammation and thickening of the 
capillary basal membrane.9 He was also 
had a hyperthyroid. Hyperthyroid is 
increasing the risk of ischemic stroke 
indirectly by trigerring atrial fibrillation 
and hypercoagulable state.10 These two 
conditions could be the main cause of 
ischemic stroke in this patient. However, 
the patient is also known to be positively 
infected with coronavirus.
Based on research by Jin et al.11 
the pathophysiology of stroke in 
COVID-19 include the hyperactivation of 
inflammatory factors that causes a fatal 
inflammatory storm and a damage of 
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coagulation system which causing the 
D-dimer and platelet abnormalities.11
Coronaviruses are able to infect 
bone marrow cells, resulting in 
inhibition of hematopoiesis, to cause 
reduced lymphocyte count, decreased 
primary platelet formation that lead to 
thrombocytopenia, along with prolonged 
activated partial thromboplastin time, 
elevated D-dimer levels. COVID-19 also 
may increases level of autoantibodies 
and immune complexes, resulting 
in specific destruction of platelets 
by the immune system. The platelet 
consumption in COVID-19 estimated to 
increase due to damage in lung tissues.15 
However, not all COVID-19 patients 
have thrombocytopenia as seen in 
this study and other studies. Fan, et al. 
report that most patients had normal 
platelet counts, with only 20.0% patients 
having mild thrombocytopenia.16 Among 
the 383 COVID-19 patients enrolled in 
retrospective study by Liu et al.,17 most 
patients were admitted with platelets 
in the normal range and a few had 
thrombocytopenia.
The pathophysiology of stroke 
in COVID-19 also could include 
hypercoagulability from critical illness 
and cardioembolism from virus-related 
cardiac injury.12 Observations reflect 
the known biology of the virus, human 
angiotensin converting enzyme, as the 
obligate receptor for the virus spike 
protein, is expressed in epithelial 
cells throughout the body, including 
in the central nervous system, raising 
the possibility of a direct role in viral 
infection.13
Mao et al.7 explained  that patients 
with  severe infection had a higher 
D-dimer levels than that of patients 
with non-severe infection. They were 
more likely to develop neurologic 
manifestations (45.5% vs 30.2%), 
especially acute cerebrovascular 
disease (5.7% vs 0.8%).7 The patient in 
this case report also showed a sign of 
severe infection  marked by a rapid 
deterioration, the presence of liver 
and kidney failure (TABLE 2) despite of 
adequate therapy has been given. An 
increasing of neutrophil-to-lymphocyte 
ratio (NLR) and reduction of absolute 
lymphocyte count (ALC) are a good 
parameters in hematology test for 
COVID-19 screening and the severtity 
of disease. This patient had a stroke in 
evolution due to his and respiratory 
distress. These may have contributed 
to its high mortality rate. To the best 
of our knowledge, this is the first case 
report of ischemic stroke in COVID-19 
positive patient in Indonesia. This case 
report will give a valuable information 
for future research. More cases with 
epidemiological data are necessary to 
support a causal relationship. 
CONCLUSION
Ischemic stroke can be present along 
with COVID-19. A further investigation 
is needed to determine the causal 
relationship.
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